BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4429112)

  • 1. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
    Arrata WS; Chatterton RT
    Am J Obstet Gynecol; 1974 Dec; 120(7):954-9. PubMed ID: 4429112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous infusion of prostaglandin F2alpha in the mid-luteal phase of the normal human menstrual cycle.
    Jewelewicz R; Cantor B; Dyrenfurth I; Warren MP; Vande Wiele RL
    Prostaglandins; 1972 Jun; 1(6):443-51. PubMed ID: 4660079
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of vaginally administered prostaglandin F2alpha on corpus luteum function.
    Bolognese RJ; Corson SL
    Am J Obstet Gynecol; 1973 Sep; 117(2):240-5. PubMed ID: 4728875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
    J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient decline in serum progesterone levels during prostaglandin F2alpha infusion in the midluteal phase of the normal human menstrual cycle.
    Coudert SP; Winter JS; Faiman C
    Am J Obstet Gynecol; 1974 Jul; 119(6):755-61. PubMed ID: 4842261
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin.
    Bergquist C; Nillius SJ; Wide L
    Contraception; 1980 Oct; 22(4):341-7. PubMed ID: 7004772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 and the luteal phase of the menstrual cycle: effects on blood progesterone, estradiol, cortisol, and growth hormone levels.
    Henzl MR; Ortega E; Cortés-Gallegos V; Tomlinson RV; Segre EJ
    J Clin Endocrinol Metab; 1973 Apr; 36(4):784-7. PubMed ID: 4686386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent versus transient stimulation of the macaque corpus luteum during prolonged exposure to human chorionic gonadotropin: a function of age of the corpus luteum.
    Ottobre JS; Stouffer RL
    Endocrinology; 1984 Jun; 114(6):2175-82. PubMed ID: 6723578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
    Fogel M; Rubin BL; Ossowski R
    Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of PGF2alpha in pseudopregnancy.
    Wentz AC; Rocco L; Jones GS
    Obstet Gynecol; 1975 Jan; 45(1):49-55. PubMed ID: 1110819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum gonadotropin and steroid patterns in early human gestation.
    Mishell DR; Thorneycroft IH; Nagata Y; Murata T; Nakamura RM
    Am J Obstet Gynecol; 1973 Nov; 117(5):631-42. PubMed ID: 4742372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate effect of prostaglandin F2alpha during the luteal phase of the menstrual cycle.
    Turksoy RN; Safaii HS
    Fertil Steril; 1975 Jul; 26(7):634-7. PubMed ID: 168099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolysis in humans and subhuman primates.
    Henzl MR
    Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbations of the human menstrual cycle by oxymetholone.
    Cox DW; Heinrichs WL; Paulsen AC; Conrad SH; Schiller HS; Hezl MR; Herrmann WL
    Am J Obstet Gynecol; 1975 Jan; 121(1):121-6. PubMed ID: 1115110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of high-dose chorionic gonadotropin on the human and rat corpus luteum and effect of gonadotropin-releasing hormone on human luteal function.
    Caldwell BV; Rotchell YE; Pang CY; Anderson GG; Kase N; Behrman HR
    Am J Obstet Gynecol; 1980 Feb; 136(4):458-64. PubMed ID: 6243862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.